← Eichor
Condition: Parkinson Disease Dementia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Parkinson Disease Dementia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06629207
Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder
NA · 1 location(s) · University of Minnesota · NCT06467461
Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA
Phase N/A · 2 location(s) · Danish Dementia Research Centre · NCT05740683
Parkinson's Disease and Movement Disorders Clinical Database
Phase N/A · 1 location(s) · University of Pennsylvania · NCT04997642
Natural History Study of Synucleinopathies
Phase N/A · 8 location(s) · NYU Langone Health · NCT01799915
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
EARLY_Phase 1 · 2 location(s) · University of Pennsylvania · NCT06932809
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Phase N/A · 1 location(s) · Douglas Scharre · NCT03019757
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Phase N/A · 2 location(s) · Tianjin Medical University · NCT07685873
Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT07720765
Proteinopathies Expression in Skin of Neurodegenerative Disorders
Phase N/A · 1 location(s) · Universidad Autonoma de San Luis Potosí · NCT06528964
Saliva and Extracellular Vesicles for Neurodegenerative Diseases
Phase N/A · 5 location(s) · Fondazione Don Carlo Gnocchi ETS · NCT06869135
The Effects of Specific tDCS on Cognition in MCI
NA · 1 location(s) · Istanbul Medipol University Hospital · NCT05919485
18F-mFBG Cardiac Uptake With Lewy Body Dementia
Phase 2 · 1 location(s) · Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radio · NCT07176286
Impact of a Biophoton Therapy on Patients With Brain Disorders
NA · 1 location(s) · First Institute of All Medicines · NCT06147999
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Phase 1/Phase 2 · 3 location(s) · Ashvattha Therapeutics, Inc. · NCT05395624
Exergaming Revolution in Dementia
NA · 1 location(s) · Eastern Switzerland University of Applied Sciences · NCT06631742
Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease
Phase 2 · 1 location(s) · The University of Queensland · NCT04643327
Quantification of Hsp90 in the Human Brain
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07380204
Retinal Imaging in Neurodegenerative Disease
Phase N/A · 1 location(s) · Duke University · NCT03233646
The Swedish BioFINDER 2 Study
NA · 2 location(s) · Skane University Hospital · NCT03174938
Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Phase 1 · 1 location(s) · National Institute of Mental Health (NIMH) · NCT04396873
Effectiveness of TeleVR App in Cognitive Decline and MCI Patients
NA · 1 location(s) · IRCCS Centro Neurolesi Bonino Pulejo · NCT06793735
Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease
NA · 3 location(s) · University Hospital, Montpellier · NCT06688968
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Dise
NA · 2 location(s) · Sanmai Technologies PBC dba Sanmai · NCT07207122
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Phase N/A · 38 location(s) · Russian Federation of Anesthesiologists and Reanimatologists · NCT03945968
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
NA · 1 location(s) · University Hospital, Bonn · NCT07324330
Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypi
Phase N/A · 3 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06846658
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125
Telehealth in Lewy Body Dementia
NA · 1 location(s) · University of Florida · NCT05014971
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.